Clinical Trial

Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors

Name: Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors — clinical trial record (NCT03915678)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: AGADIR

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Basket trial concept to independently and simultaneously assess the effects of the association of atezolizumab + BDB001 + radiotherapy in multiple solid tumors.

Protocol Amendment History 1 change

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-25

Trial Details

NCT Number	NCT03915678
Lead Sponsor	Institut Bergonié Collaborators: Roche Pharma AG, National Cancer Institute, France, Eikon Therapeutics
Conditions	Solid Tumor, Adult, Pancreatic Cancer, Virus-associated Tumors, Non Small Cell Lung Cancer, Melanoma, Bladder Cancer, Triple Negative Breast Cancer
Enrollment	247 participants
Start Date	2021-03-31
Primary Completion	2026-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-24